Jaden Schaefer

Healthcare in the US is, you know, obviously kind of governed by a patchwork of state level licensing rules.

And, you know, I like know for in my own family, I have an uncle that's a doctor and

moving when he when his family moves he's moved between many different states before and originally is from Canada and getting the licenses in every state and board certification approval like there's a lot that goes into just a doctor moving between states sometimes months or years for some of this stuff and so

This is a complicated kind of process.

I think doctors are typically kind of restricted to treating patients only where they're licensed.

And if they want to move somewhere, then they have that whole issue, which I think is just another strain on the healthcare system that a system like this could help with and help alleviate.

Automating a big chunk of all of this kind of clinical decision making has a bunch of, I think, additional scrutiny around liability.

There's safety and oversight that you have to think about.

But still, even with all of that, investors really believe that the timing's right.

Personally, I would agree with them on that.

Sarger, who is the CRV general partner, so he joined the board and he was kind of the person like leading the charge over at CRV on this whole deal.

But he is arguing that telemedicine infrastructure, which was kind of normalized during the pandemic, basically opened up the door for some of these new care models, which are layered on top of AI.

He said, quote, there are many challenges, but it's not SpaceX sending astronauts to the moon.

He was also an early investor in like DoorDash, Mercury, and Ring.

And so he's...

basically framing Lotus as kind of a high conviction bet.

Primary care doctors right now are in short supply nationwide.

And so Lotus thinks that their model can handle up to 10 times as many patients as a traditional practice, even if they're still capping visits at about 15 minutes.

And it's interesting because it's like, well, how come they could only do 10 times as many patients as a traditional practice?

And it's because they still have to hire actual doctors to review everything.